PharmaEssentiaTPE:6446 +3.58%82 PB Ratio is 16.77 as of Jul. 07, 2026, which is 91% above its 10-year median of 8.77. GuruFocus rates TPE:6446 with a GF Score™ of 82/100 and a GF Value™ of NT$1,352.07 (Fairly Valued). The stock has 6 warning signs investors should review. Among 921 Drug Manufacturers companies, PharmaEssentia ranks worse than 95.66% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-07), PharmaEssentia's share price is NT$1445.00. PharmaEssentia's Book Value per Share for the quarter that ended in Dec. 2025 was NT$86.15. Hence, PharmaEssentia's PB Ratio of today is 16.77.
Warning Sign:
PharmaEssentia Corp stock PB Ratio (=16.19) is close to 3-year high of 16.19.
The historical rank and industry rank for PharmaEssentia's PB Ratio or its related term are showing as below:
TPE:6446'
s PB Ratio Range Over the Past 10 Years
Min: 3.88 Med: 8.77 Max: 48.48
Current: 16.77
During the past 13 years, PharmaEssentia's highest PB Ratio was 48.48. The lowest was 3.88. And the median was 8.77.
TPE:6446's PB Ratio is ranked worse than 95.66% of 921
companies
in the Drug Manufacturers industry
Industry Median: 1.93
vs TPE:6446: 16.77
During the past 12 months, PharmaEssentia's average Book Value Per Share Growth Rate was 12.30% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 33.40% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 53.60% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 31.60% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of PharmaEssentia was 216.20% per year. The lowest was -20.00% per year. And the median was 33.40% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
PharmaEssentia PB Ratio Related Terms
PharmaEssentia PB Ratio Historical Data
* Premium members only.
The historical data trend for PharmaEssentia's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, PharmaEssentia's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PharmaEssentia PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, PharmaEssentia's PB Ratio distribution charts can be found below:
* The bar in red indicates where PharmaEssentia's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
PharmaEssentia's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
PharmaEssentia (TPE:6446) has a PB Ratio of 16.77 as of Jul. 07, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on PharmaEssentia and its competitors. This is 91% above median its historical median of 8.77. Over the past decade, PharmaEssentia's PB Ratio has ranged from 3.88 to 48.48. According to the industry distribution chart, PharmaEssentia ranks #881 out of 921 companies in the Drug Manufacturers industry, placing it in the top 95.7%.
Is PharmaEssentia's PB Ratio too high?
PharmaEssentia's current PB Ratio of 16.77 is 91% above median its 10-year median of 8.77. Over the past 10 years, this metric has ranged from a low of 3.88 to a high of 48.48. The Drug Manufacturers industry median PB Ratio is 1.93. PharmaEssentia's value of 16.77 is 768.9% above this industry median. Based on the distribution chart, PharmaEssentia ranks #881 out of 921 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, PharmaEssentia has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PharmaEssentia's PB Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, PharmaEssentia ranks #881 out of 921 companies for PB Ratio. This places PharmaEssentia in the lower half of its industry. The industry median PB Ratio is 1.93. PharmaEssentia's value of 16.77 is 768.9% above this benchmark. Historically, PharmaEssentia's own PB Ratio has ranged from 3.88 to 48.48 over the past decade. While the company's 10-year median is 8.77 vs. the industry median of 1.93, PharmaEssentia has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.93, based on 921 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PharmaEssentia's current PB Ratio of 16.77 is 768.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on PharmaEssentia and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PharmaEssentia's current PB Ratio is 16.77, which is 91% above median its own 10-year median of 8.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaEssentia stock overvalued right now?
Based on GuruFocus' analysis, PharmaEssentia (TPE:6446) is currently considered Fairly Valued. The stock's GF Value™ is NT$1,352.07, compared to a current price of NT$1,445.00 — trading 6.9% above its estimated fair value. The current PB Ratio is 16.77, which is 91% above median its 10-year median of 8.77 and 768.9% above the Drug Manufacturers industry median of 1.93. PharmaEssentia's overall GF Score™ is 82/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For PharmaEssentia (TPE:6446), the current PB Ratio is 16.77 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PharmaEssentia (TPE:6446) Overvalued in 2026?
Based on GuruFocus' analysis, PharmaEssentia stock appears to be overvalued.
The current stock price of NT$1,445.00 is trading 6.9% above its estimated GF Value™ of NT$1,352.07.
GuruFocus considers PharmaEssentia to be Fairly Valued.
Key valuation signals for TPE:6446:
PB Ratio: 16.77 (91% above median its 10-year median of 8.77)
GF Value™: NT$1,352.07 vs. price of NT$1,445.00 (6.9% above fair value)
Industry Position: 768.9% above the Drug Manufacturers median (#881 of 921)
No single metric tells the full story. See the TPE:6446 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PharmaEssentia Corp engages in medicine discovery, supplements in developing specialty pharmaceutical reagents, API and new drug patterns developments. Its products include BESREMi, Ropeginterferon alfa-2b, Ropeg + anti PD-1, PEG-IL-2, PEG-Cytokines, PD-1-IL-2v, NY-ESO-1 TCR-T, among others. It derives revenue from medicine products sales from contracts with customers.
82GF Score
Get the complete analysis for TPE:6446
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6446 has been successfully added to your 
